Docosahexaenoic Acid Reverses Epithelial-Mesenchymal Transition and Drug Resistance by Impairing the PI3K/AKT/Nrf2/GPX4 Signalling Pathway in Docetaxel-Resistant PC3 Prostate Cancer Cells Articles by the same authors

Folia Biologica > Archive > 2022, Vol. 68 > Issue 2 > p. 59 > Articles by the same authors

Fol. Biol. 2022, 68, 59-71

https://doi.org/10.14712/fb2022068020059

Docosahexaenoic Acid Reverses Epithelial-Mesenchymal Transition and Drug Resistance by Impairing the PI3K/AKT/Nrf2/GPX4 Signalling Pathway in Docetaxel-Resistant PC3 Prostate Cancer Cells

Z. C. Shao^1,2, B. H. Zhu², A. F. Huang², M. Q. Su^1,2, L. J. An^1,2, Z. P. Wu^2,3, Y. J. Jiang², H. Guo², X.-Q. Han², Chi-Ming Liu²

¹College of Chemistry and Bio-engineering, Yichun University, Yuanzhou District, Yichun 336000, Jiangxi Province, China
²School of Medicine, Yichun University, Yuanzhou District, Yichun 336000, Jiangxi Province, China
³School of Aesthetic Medicine, Yuanzhou District, Yichun 336000, Jiangxi Province, China

Received November 2021
Accepted April 2022

Folia Biologica
Journal of Cellular and Molecular Biology, Charles University

Fol. Biol. 2022, 68, 59-71

Docosahexaenoic Acid Reverses Epithelial-Mesenchymal Transition and Drug Resistance by Impairing the PI3K/AKT/Nrf2/GPX4 Signalling Pathway in Docetaxel-Resistant PC3 Prostate Cancer Cells

Individual author index pages

Other articles of these authors

Archive

Folia BiologicaJournal of Cellular and Molecular Biology, Charles University

Fol. Biol. 2022, 68, 59-71

Docosahexaenoic Acid Reverses Epithelial-Mesenchymal Transition and Drug Resistance by Impairing the PI3K/AKT/Nrf2/GPX4 Signalling Pathway in Docetaxel-Resistant PC3 Prostate Cancer Cells

Individual author index pages

Other articles of these authors

Archive

Folia Biologica
Journal of Cellular and Molecular Biology, Charles University